M&A Deal Summary

Novo Holdings A/S Acquires Catalent

On February 5, 2024, corporate investor Novo Holdings A/S acquired life science company Catalent for 16.5B USD

Acquisition Highlights
  • This is Novo Holdings A/S’s 6th transaction in the Life Science sector.
  • This is Novo Holdings A/S’s largest (disclosed) transaction.
  • This is Novo Holdings A/S’s 6th transaction in the United States.
  • This is Novo Holdings A/S’s 2nd transaction in New Jersey.

M&A Deal Summary
Date 2024-02-05
Target Catalent
Sector Life Science
Buyer(s) Novo Holdings A/S
Deal Type Going Private
Deal Value 16.5B USD
Advisor(s) Citigroup Investment Banking
J.P. Morgan Securities (Financial)
Skadden, Arps, Slate, Meagher & Flom (Legal)

Target

Catalent

Somerset, New Jersey, United States
website
Catalent is a provider of solutions for drugs, biologics and consumer health products. Among its core offerings, it develops and manufactures oral and sterile medication in nearly all dosage forms, holds patents for softgel (e.g. “Liqui-Caps” and “Vegicaps”) and Zydis fast-dissolve technologies used in many popular prescription and over-the-counter medicine. Catalent was founded in 2007 and is based in Somerset, New Jersey.

Search 192,723 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Novo Holdings A/S

Investor Investor Investor Investor Investor

website

Category Corporate Investor
Founded 1999
Size Middle-Market
Type Sector Focused
DESCRIPTION

Novo Holdings A/S is a Danish holding company and the investment arm of the Novo Nordisk Foundation. Novo Holdings' objective is to grow the assets of the Foundation and improve the lives of people around the world. In addition to investing in equity and fixed income securities, Novo Holdings pursues direct investments in life science companies. Novo Holdings A/S was established in 1999 and is headquartered in Hellerup, Denmark.

DEAL STATS #
Overall 12 of 12
Sector (Life Science) 6 of 6
Type (Going Private) 2 of 2
State (New Jersey) 2 of 2
Country (United States) 6 of 6
Year (2024) 1 of 1
Size (of disclosed) 1 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-06-21 Ellab

Hilleroed, Denmark

Ellab is a manufacturer of solutions for measuring, recording, monitoring, and validating critical parameters of thermal processing. Ellab offers a product range of high-precision systems for temperature, pressure, and humidity monitoring and validation based on either data loggers or thermocouple-based wired instruments. Ellab was founded in 1949 and is based in Hilleroed, Denmark.

Buy -
Mergr

Product

Company

Legal